Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk PatientsBacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Recurrent Infection, Reinfection, bacterial infectious disease, gram-positive bacterial infectionsRecruitingPhase 1 / Phase 22026-09-23NCT06306014

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Exeliom Biosciences2
Hospices Civils de Lyon429

10 results · Page 1 of 1

Swipe the table sideways for more columns.